Sarah E Marvin1, David J Miklowitz2, Mary P O'Brien2, Tyrone D Cannon1,3. 1. Department of Psychology, University of California at Los Angeles, Los Angeles, California, USA. 2. Department of Psychiatry, UCLA Semel Institute, Los Angeles, California, USA. 3. Department of Psychology, Psychiatry, and Human Genetics, University of California at Los Angeles, Los Angeles, California, USA.
Abstract
AIM: Family psychoeducation is an effective adjunct to pharmacotherapy in delaying relapse among patients with schizophrenia and bipolar disorder. This study tested the treatment adherence and competence of newly trained clinicians to an adaptation of family-focused therapy for individuals at clinical high risk for psychosis (FFT-CHR). METHODS: The sample included 103 youth or young adults (ages 12-30 years) who had attenuated positive symptoms of psychosis. Families participated in a randomized trial comparing two psychosocial interventions: FFT-CHR (18 sessions over 6 months) and enhanced care (EC; 3 sessions over 1 month). Following a 1.5-day training seminar, 24 clinicians from eight study sites received teleconference supervision in both treatment protocols for the 2-year study period. Treatment fidelity was rated with the 13-item Therapy Competence and Adherence Scales, Revised. RESULTS: Supervisors classified 90% of treatment sessions as above acceptable fidelity thresholds (ratings of 5 or better on a 1-7 scale of overall fidelity). As expected, fidelity ratings indicated that FFT-CHR included a greater emphasis on communication and problem-solving skills training than EC, but ratings of non-specific clinician skills, such as maintaining rapport and appropriately pacing sessions, did not differ between conditions. Treatment fidelity was not related to the severity of symptoms or family conflict at study entry. CONCLUSIONS:FFT-CHR can be administered with high levels of fidelity by clinicians who receive training and supervision. Future studies should examine whether there are more cost-effective methods for training, supervising and monitoring the fidelity of FFT-CHR.
RCT Entities:
AIM: Family psychoeducation is an effective adjunct to pharmacotherapy in delaying relapse among patients with schizophrenia and bipolar disorder. This study tested the treatment adherence and competence of newly trained clinicians to an adaptation of family-focused therapy for individuals at clinical high risk for psychosis (FFT-CHR). METHODS: The sample included 103 youth or young adults (ages 12-30 years) who had attenuated positive symptoms of psychosis. Families participated in a randomized trial comparing two psychosocial interventions: FFT-CHR (18 sessions over 6 months) and enhanced care (EC; 3 sessions over 1 month). Following a 1.5-day training seminar, 24 clinicians from eight study sites received teleconference supervision in both treatment protocols for the 2-year study period. Treatment fidelity was rated with the 13-item Therapy Competence and Adherence Scales, Revised. RESULTS: Supervisors classified 90% of treatment sessions as above acceptable fidelity thresholds (ratings of 5 or better on a 1-7 scale of overall fidelity). As expected, fidelity ratings indicated that FFT-CHR included a greater emphasis on communication and problem-solving skills training than EC, but ratings of non-specific clinician skills, such as maintaining rapport and appropriately pacing sessions, did not differ between conditions. Treatment fidelity was not related to the severity of symptoms or family conflict at study entry. CONCLUSIONS: FFT-CHR can be administered with high levels of fidelity by clinicians who receive training and supervision. Future studies should examine whether there are more cost-effective methods for training, supervising and monitoring the fidelity of FFT-CHR.
Authors: Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods Journal: Schizophr Bull Date: 2003 Impact factor: 9.306
Authors: Mary P O'Brien; Jamie L Gordon; Carrie E Bearden; Steve R Lopez; Alex Kopelowicz; Tyrone D Cannon Journal: Schizophr Res Date: 2005-11-23 Impact factor: 4.939
Authors: Danielle A Schlosser; David J Miklowitz; Mary P O'Brien; Sandra D De Silva; Jamie L Zinberg; Tyrone D Cannon Journal: Early Interv Psychiatry Date: 2011-12-20 Impact factor: 2.732
Authors: David J Miklowitz; David A Axelson; Boris Birmaher; Elizabeth L George; Dawn O Taylor; Christopher D Schneck; Carol A Beresford; L Miriam Dickinson; W Edward Craighead; David A Brent Journal: Arch Gen Psychiatry Date: 2008-09
Authors: David J Miklowitz; Michael W Otto; Ellen Frank; Noreen A Reilly-Harrington; Jane N Kogan; Gary S Sachs; Michael E Thase; Joseph R Calabrese; Lauren B Marangell; Michael J Ostacher; Jayendra Patel; Marshall R Thomas; Mako Araga; Jodi M Gonzalez; Stephen R Wisniewski Journal: Am J Psychiatry Date: 2007-09 Impact factor: 18.112
Authors: David J Miklowitz; Mary P O'Brien; Danielle A Schlosser; Jean Addington; Kristin A Candan; Catherine Marshall; Isabel Domingues; Barbara C Walsh; Jamie L Zinberg; Sandra D De Silva; Michelle Friedman-Yakoobian; Tyrone D Cannon Journal: J Am Acad Child Adolesc Psychiatry Date: 2014-06-02 Impact factor: 8.829
Authors: Lisa A O'Donnell; Marc J Weintraub; Alissa J Ellis; David A Axelson; Robert A Kowatch; Christopher D Schneck; David J Miklowitz Journal: Fam Process Date: 2020-02-03
Authors: David J Miklowitz; Christopher D Schneck; Patricia D Walshaw; Manpreet K Singh; Aimee E Sullivan; Robert L Suddath; Marcy Forgey Borlik; Catherine A Sugar; Kiki D Chang Journal: JAMA Psychiatry Date: 2020-05-01 Impact factor: 21.596
Authors: Mary P O'Brien; David J Miklowitz; Kristin A Candan; Catherine Marshall; Isabel Domingues; Barbara C Walsh; Jamie L Zinberg; Sandra D De Silva; Kristen A Woodberry; Tyrone D Cannon Journal: J Consult Clin Psychol Date: 2013-11-04
Authors: Gina Dimitropoulos; James D Lock; William Stewart Agras; Harry Brandt; Katherine A Halmi; Booil Jo; Walter H Kaye; Leora Pinhas; Denise E Wilfley; D Blake Woodside Journal: Eur Eat Disord Rev Date: 2019-07-11